Loncar Cancer Immunotherapy ETF (NQ: CNCR )
29.35
USD
-0.29
(-0.98%)
Official Closing Price
Updated: 4:00 PM EDT, Apr 16, 2021
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 4,300 |
| Open | 29.91 |
| Bid (Size) | 29.30 (1) |
| Ask (Size) | 29.39 (1) |
| Prev. Close | 29.64 |
| Today's Range | 29.25 - 29.91 |
| 52wk Range | 21.33 - 35.82 |
| Shares Outstanding | N/A |
| Dividend Yield | 1.19% |
Top News
More News
As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally
December 03, 2020
Performance
More News
Read More
Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine
November 27, 2020
Biotech ETFs Poised for Gains after Moderna Vaccine News
November 16, 2020
Will Moderna Vaccine News Boost Biotech ETFs?
November 12, 2020
This Week's Top Performing ETFs: 09/20/2020
September 21, 2020
This Week's Top Performing ETFs: 09/13/2020
September 14, 2020
6 Sector ETFs Surviving the Market Rout
September 15, 2020
5 ETFs Jump After Three-Day Rout: Will The Rally Last?
September 10, 2020
Moderna Vaccine Optimism Could Drive Biotech ETFs
August 26, 2020
Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data
August 28, 2020
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.